Xinganmine (compound aminophenol alkamine tablets) were launched by Changchun Dirui Pharmaceutical.

Changchun Dirui Pharmaceutical Co., Ltd. was established in 2004 and is a national high-tech enterprise integrating pharmaceutical research and development, production and sales. Since its establishment, the company has developed rapidly and its comprehensive strength has been continuously improved. In recent years, it has obtained taxpayers with tax credit rating A grades, technology-based small and medium-sized enterprises, Jilin Province's "little giant" enterprise, and Changchun City's "specialized and specialized" Small and medium-sized enterprises, Changchun City's science and technology-based "little giant" enterprise, etc. The company is an enterprise in Jilin Province that has passed the on-site verification of the quality and efficacy consistency evaluation of generic drugs. Cephalexin capsules (0.25g) and acetaminophen tablets (0.5g) have passed the quality and efficacy consistency evaluation and obtained approval documents.

The company covers an area of ​​27,162 square meters and has 10,671 square meters of GMP standard factory, including 2,174 square meters of standard warehouse, with five production workshops, including solid preparations, cephalosporin preparations, eye drops, liquid preparations and packaging. The production scope includes tablets ( Contains cephalosporins, hormones), hard capsules (including cephalosporins), granules, powders, eye drops, nose drops, ear drops, products cover entrapment, antibacterial, anti-inflammatory, antipyretic and analgesic , liver, gallbladder, gastrointestinal, cardiovascular and cerebrovascular, kidney and yang strengthening, vitamins, cough and relieve asthma, rheumatism, gynecology, pediatrics, etc., a total of 80 varieties and 102 documents.

The company has 10 functional departments including sales, R&D, production, and quality. There are currently 240 employees and 76 employees above college degree. The high-quality management team leads employees to make steady progress towards the company's established goals.

The company conscientiously implements the quality policy of "based on high-tech, pursuing quality, strengthening system control, and ensuring customer interests", and the product quality control system has been continuously improved and improved. In order to improve product quality, the company's R&D investment has increased year by year. Other eye drop varieties have been gradually selected for quality and efficacy consistency evaluation, so that the company's product quality can be further in line with international standards and the quality has reached a new level.

Changchun Dirui Pharmaceutical Co., Ltd. takes "making fine medicines and creating healthy life" as its corporate philosophy, based on its own R&D advantages, constantly pursues high quality and high efficacy, and uses Dirui people's wisdom and innovation to contribute to the health cause of human beings. .